Alopecia areata - need for a revision in morphological classification and scoring
Main Article Content
Abstract
Background: Scalp hair is believed to be the commonest site involved in Alopecia Areata (AA), and the morphological classification and scoring of the disease mainly concentrate on scalp hair involvement.
Objectives: This study aims to assess terminal hair involvement across different body sites in patients with alopecia areata (AA), evaluate the current classification and scoring systems, and propose potential revisions and solutions.
Methods: Data of patients of AA registered over 4 years at our institute from April 2021 to March 2025 was analyzed for the site(s) of involvement, morphological type of disease, and associated cutaneous/medical disorders. The data was analyzed to assess whether all the patients could be classified into any one of the currently known morphological types and scored in an ideal fashion.
Results: A total of 1010 patients with alopecia areata (AA) were seen over 4 years, including 602 males and 408 females. Scalp involvement alone was observed only in 488 patients (48.3%) patients while 522 patients (51.7%) had terminal hair involvement beyond the scalp. Among the 602 males, 394 were older than 18 years, and in this subgroup, approximately 63% (248/394) had beard hair involvement, either alone or along with scalp hair. The multifocal type was the most common morphological pattern of AA observed. However, some patients with extensive involvement of the scalp, beard, and body hair could not be classified into any known morphological type. For this pattern, we propose the term alopecia subuniversalis.
Conclusions: Given that beard hair is affected as commonly as scalp hair, we propose the use of a composite scoring system to assess the severity of alopecia areata (AA) involving the beard, eyebrows, and eyelashes. Additionally, we propose a new morphological subtype—alopecia subuniversalis—to describe scalp AA with extensive involvement of the other hair-bearing areas of the face and body.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clinical, Cosmetic and Investigational Dermatology. 2015;8:397.
3. Harries M, Macbeth AE, Holmes S et al. The epidemiology of alopecia areata: a population-based cohort study in UK primary care. Br J Dermatol 2022; 186:257–65.
4. Olsen EA, Roberts J, Sperling L, Tosti A, Shapiro J, McMichael A, Bergfeld W, Callender V, Mirmirani P, Washenik K, Whiting D. Objective outcome measures: collecting meaningful data on alopecia areata. Journal of the American Academy of Dermatology. 2018 Sep 1;79(3):470-8.
5. Jang YH, Moon SY, Lee WJ, Lee SJ, Lee WK, Park BC, Kim H. Alopecia areata progression index, a scoring system for evaluating overall hair loss activity in alopecia areata patients with pigmented hair: a development and reliability assessment. Dermatology. 2016;232(2):143-9.
6. Olsen EA, Roberts J, Sperling L, Tosti A, Shapiro J, McMichael A, Bergfeld W, Callender V, Mirmirani P, Washenik K, Whiting D. Objective outcome measures: collecting meaningful data on alopecia areata. Journal of the American Academy of Dermatology. 2018 Sep 1;79(3):470-8.
7. Waśkiel‐Burnat A, Rakowska A, Sikora M, Olszewska M, Rudnicka L. Alopecia areata predictive score: A new trichoscopy‐based tool to predict treatment outcome in patients with patchy alopecia areata. Journal of Cosmetic Dermatology. 2020 Mar;19(3):746-51.
8. Manjaly P, Li SJ, Tkachenko E et al. Development and validation of the Brigham Eyelash Tool for Alopecia (BELA): a measure of eyelash alopecia areata. J Am Acad Dermatol 2021; 85:271–2. 22.
9. Stefanis A, Arenberger P, Arenbergerova M et al. Alopecia Barbae Severity Score: a novel scoring system to estimate the extent of beard loss and success of treatment. Br J Dermatol 2021; 185:847–9.
10. Liu LY, King BA, Craiglow BG. Health-related quality of life (HRQoL) among patients with alopecia areata (AA): a systematic review. J Am Acad Dermatol. 2016; 75: 806-812.e3.
11. Rees H, Wall D, Bokhari L et al. Reliability and validity of a measure to assess the health-related quality of life of women with alopecia areata. Cli Exp Dermatol 2023; 48:681–4.
12. Al-Ajlan A, Alqahtani ME, Alsuwaidan S, Alsalhi A. Prevalence of Alopecia Areata in Saudi Arabia: Cross-Sectional Descriptive Study. Cureus. 2020 Sep;12(9).
13. Alshahrani AA, Al-Tuwaijri R, Abuoliat ZA, Alyabsi M, AlJasser MI, Alkhodair R. Prevalence and Clinical Characteristics of Alopecia Areata at a Tertiary Care Center in Saudi Arabia. Dermatology Research and Practice. 2020 Mar 13;2020.
14. Majid I, Sameem F, Sultan J, Aleem S. Alopecia areata severity index (AASI): A reliable scoring system to assess the severity of alopecia areata on face and scalp—a pilot study. Journal of Cosmetic Dermatology. 2021 Aug;20(8):2565-70.